Skip to content
← Lobby Directory
AT
NGOATMF

Access to Medicine Foundation

Amsterdam, NETHERLANDSFoundationReg: 586380015959-83Since 10/02/2015

Budget

€3,916,955

EP Access

0

accredited persons

Staff

3

0.75 FTE

EU Grants

None

Mission & Goals

The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. Our mission is to stimulate and guide healthcare companies to do more for people living in low- and middle-income countries without access to medicine. We talk to experts about the actions healthcare companies can and should be taking and then analyse what they are actually doing. In practice, that means analysing healthcare companies’ actions and policies regarding access to medicine using a rigorous scoring and evaluation process. We benchmark companies against each other, and identify best practices and progress gaps. We make all of our results public and use our findings in our own outreach work to expand good practice across the industry. The Foundation publishes the Access to Medicine Index (ATMI), the Antimicrobial Resistance Benchmark (ARMB) and various thematic studies, offering deep dives on critical access issues.

EU Legislative Interests

Access to medicine, antimicrobial resistance, CSR, sustainable development, research and development, global health

Interests Represented

Does not represent commercial interests

Member Of

Dutch Global Health Hub Dutch Global Health Alliance MPP Coalition for Access to NCD Medicines and Products Rome Peadiatrics (Gap-f) Reproductive Health Supplies Coalition (RHSC) Working Group on Good Pharma policies with AUDA-NEPAD WHO's Global Diabetes Compact Antimicrobial Resistance Access and Stewardship Initiative (AMRASI) Antimicrobial Resistance Multi-Stakeholder Partnership Platform WHO guidance on waste and wastewater management group Investor Action on Antimicrobial Resistance SDG3 Collaborative Lancet Global Health Commission on Medical Oxygen Security Oxygen Access Collaborators group Global Oxygen Alliance (GO2AL) O2AL Working Group 2 on Innovative Supply Chain and Market Shaping

Organisation Members

N/A

Additional Information

Financial information for 2024 fiscal year will not be finalized until the end of March 2025. That is why 2023 numbers are provided above.

Commissioner Meetings

No recorded meetings with EU commissioners.